VAERS Explorer
Back to explore

Report #2873460

Received Nov 19, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
WA
Recovered
Unknown
Vaccinated
Dec 6, 2021
Onset
Oct 14, 2025
Days to onset
1408
Hospital days
—

Vaccines (4)

TypeNameManufacturerDoseLotRoute / Site
HEPHEP B (RECOMBIVAX HB)MERCK & CO. INC.1——
HEPHEP B (RECOMBIVAX HB)MERCK & CO. INC.2——
HEPHEP B (RECOMBIVAX HB)MERCK & CO. INC.3——
HEPHEP B (RECOMBIVAX HB)MERCK & CO. INC.UNK——

Symptoms (2)

Antibody test negativeWrong product administered

Symptom narrative

administration of RECOMBIVAX HB Dialysis Formulation to a patient on 23OCT2025 instead of the regular adult formulation.; administration of RECOMBIVAX HB Dialysis Formulation to a patient on 23OCT2025 instead of the regular adult formulation.; RECOMBIVAX HB on 06DEC2021, 03JAN2022; Patient's titers came back "not immune"; This spontaneous report was received from a nurse and refers to a 37-years-old male patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 06-Dec-2021, the patient was vaccinated with Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB), dose number 1, (lot # and expiration date were not reported). On 03-Jan-2022, the patient was vaccinated with Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB), dose number 2, (lot # and expiration date were not reported) (inappropriate schedule of product administration). On 06-Jun-2022, the patient was vaccinated with Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB), dose number 3, (lot # and expiration date were not reported as a prophylaxis. On 14-Oct-2025, the patient titers came back not immune (antibody NOS negative). Therefore, on 23-Oct-2025, the patient was inadvertently administrated with Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB), (Booster dose), (lot # and expiration date were not reported) dialysis formulation to a patient instead of the regular adult formulation, as a prophylaxis (accidental overdose, wrong dosage formulation). The causal relationship between the event of antibody NOS negative and Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB) was not provided. Lot # is being requested and will be submitted if received.